Bausch Health Companies Inc.
BHC
$4.96
-$0.09-1.78%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 6.70% | 5.80% | 7.01% | 8.41% | 9.87% |
| Total Other Revenue | 2.80% | 10.78% | 18.18% | 19.79% | 13.83% |
| Total Revenue | 6.66% | 5.86% | 7.13% | 8.53% | 9.91% |
| Cost of Revenue | 8.30% | 6.59% | 7.48% | 8.64% | 8.71% |
| Gross Profit | 5.99% | 5.56% | 6.98% | 8.49% | 10.41% |
| SG&A Expenses | 4.48% | 4.05% | 10.36% | 12.76% | 12.97% |
| Depreciation & Amortization | -7.06% | -6.91% | -3.15% | -1.76% | 0.00% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.06% | 3.42% | 6.51% | 7.99% | 8.55% |
| Operating Income | 17.47% | 16.44% | 9.79% | 10.89% | 15.97% |
| Income Before Tax | 119.76% | 1,161.22% | 179.38% | 158.51% | 142.82% |
| Income Tax Expenses | 3.35% | 18.45% | 52.29% | 73.08% | 8.14% |
| Earnings from Continuing Operations | 266.67% | 247.93% | 109.47% | 83.09% | 88.22% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 42.31% | 5.13% | 38.89% | 70.83% | 36.84% |
| Net Income | 441.30% | 303.37% | 120.81% | 91.21% | 92.23% |
| EBIT | 17.47% | 16.44% | 9.79% | 10.89% | 15.97% |
| EBITDA | 8.52% | 7.44% | 4.74% | 5.77% | 9.05% |
| EPS Basic | 427.19% | 298.52% | 120.24% | 91.15% | 92.13% |
| Normalized Basic EPS | 25.83% | 34.68% | 30.76% | 74.46% | 72.29% |
| EPS Diluted | 419.69% | 297.91% | 120.00% | 90.92% | 91.95% |
| Normalized Diluted EPS | 25.95% | 34.83% | 30.94% | 74.46% | 72.28% |
| Average Basic Shares Outstanding | 0.96% | 2.08% | 1.80% | 1.82% | 1.87% |
| Average Diluted Shares Outstanding | 0.96% | 2.07% | 1.80% | 1.81% | 1.87% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |